United States Glial Cell Line Derived Neurotrophic Factor Market Report 2018

February 2018 | 100 pages | ID: UB2A9397A6BEN
QYResearch

Abstracts

In this report, the United States Glial Cell Line Derived Neurotrophic Factor market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Glial Cell Line Derived Neurotrophic Factor in these regions, from 2013 to 2025 (forecast).

United States Glial Cell Line Derived Neurotrophic Factor market competition by top manufacturers/players, with Glial Cell Line Derived Neurotrophic Factor sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• GlaxoSmithKline Plc
• Treeway BV
• UniQure NV

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• GSK-812
• LAUR-301
• TW-002
• AMT-090
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Amyotrophic Lateral Sclerosis
• Brain Ischemia
• Parkinson's Disease
• Retinal Degeneration
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Glial Cell Line Derived Neurotrophic Factor Market Report 2018

1 GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR OVERVIEW

1.1 Product Overview and Scope of Glial Cell Line Derived Neurotrophic Factor
1.2 Classification of Glial Cell Line Derived Neurotrophic Factor by Product Category
  1.2.1 United States Glial Cell Line Derived Neurotrophic Factor Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Glial Cell Line Derived Neurotrophic Factor Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 GSK-812
  1.2.4 LAUR-301
  1.2.5 TW-002
  1.2.6 AMT-090
  1.2.7 Others
1.3 United States Glial Cell Line Derived Neurotrophic Factor Market by Application/End Users
  1.3.1 United States Glial Cell Line Derived Neurotrophic Factor Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Amyotrophic Lateral Sclerosis
  1.3.3 Brain Ischemia
  1.3.4 Parkinson's Disease
  1.3.5 Retinal Degeneration
  1.3.6 Others
1.4 United States Glial Cell Line Derived Neurotrophic Factor Market by Region
  1.4.1 United States Glial Cell Line Derived Neurotrophic Factor Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Glial Cell Line Derived Neurotrophic Factor Status and Prospect (2013-2025)
  1.4.3 Southwest Glial Cell Line Derived Neurotrophic Factor Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Glial Cell Line Derived Neurotrophic Factor Status and Prospect (2013-2025)
  1.4.5 New England Glial Cell Line Derived Neurotrophic Factor Status and Prospect (2013-2025)
  1.4.6 The South Glial Cell Line Derived Neurotrophic Factor Status and Prospect (2013-2025)
  1.4.7 The Midwest Glial Cell Line Derived Neurotrophic Factor Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Glial Cell Line Derived Neurotrophic Factor (2013-2025)
  1.5.1 United States Glial Cell Line Derived Neurotrophic Factor Sales and Growth Rate (2013-2025)
  1.5.2 United States Glial Cell Line Derived Neurotrophic Factor Revenue and Growth Rate (2013-2025)

2 UNITED STATES GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Glial Cell Line Derived Neurotrophic Factor Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Glial Cell Line Derived Neurotrophic Factor Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Glial Cell Line Derived Neurotrophic Factor Average Price by Players/Suppliers (2013-2018)
2.4 United States Glial Cell Line Derived Neurotrophic Factor Market Competitive Situation and Trends
  2.4.1 United States Glial Cell Line Derived Neurotrophic Factor Market Concentration Rate
  2.4.2 United States Glial Cell Line Derived Neurotrophic Factor Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Glial Cell Line Derived Neurotrophic Factor Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Glial Cell Line Derived Neurotrophic Factor Sales and Market Share by Region (2013-2018)
3.2 United States Glial Cell Line Derived Neurotrophic Factor Revenue and Market Share by Region (2013-2018)
3.3 United States Glial Cell Line Derived Neurotrophic Factor Price by Region (2013-2018)

4 UNITED STATES GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Glial Cell Line Derived Neurotrophic Factor Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Glial Cell Line Derived Neurotrophic Factor Revenue and Market Share by Type (2013-2018)
4.3 United States Glial Cell Line Derived Neurotrophic Factor Price by Type (2013-2018)
4.4 United States Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate by Type (2013-2018)

5 UNITED STATES GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Glial Cell Line Derived Neurotrophic Factor Sales and Market Share by Application (2013-2018)
5.2 United States Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 GlaxoSmithKline Plc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Glial Cell Line Derived Neurotrophic Factor Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GlaxoSmithKline Plc Glial Cell Line Derived Neurotrophic Factor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Treeway BV
  6.2.2 Glial Cell Line Derived Neurotrophic Factor Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Treeway BV Glial Cell Line Derived Neurotrophic Factor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 UniQure NV
  6.3.2 Glial Cell Line Derived Neurotrophic Factor Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 UniQure NV Glial Cell Line Derived Neurotrophic Factor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview

7 GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR MANUFACTURING COST ANALYSIS

7.1 Glial Cell Line Derived Neurotrophic Factor Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Glial Cell Line Derived Neurotrophic Factor

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Glial Cell Line Derived Neurotrophic Factor Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Glial Cell Line Derived Neurotrophic Factor Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Glial Cell Line Derived Neurotrophic Factor Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Glial Cell Line Derived Neurotrophic Factor Sales Volume Forecast by Type (2018-2025)
11.3 United States Glial Cell Line Derived Neurotrophic Factor Sales Volume Forecast by Application (2018-2025)
11.4 United States Glial Cell Line Derived Neurotrophic Factor Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Glial Cell Line Derived Neurotrophic Factor
Figure United States Glial Cell Line Derived Neurotrophic Factor Market Size (K Pcs) by Type (2013-2025)
Figure United States Glial Cell Line Derived Neurotrophic Factor Sales Volume Market Share by Type (Product Category) in 2017
Figure GSK-812 Product Picture
Figure LAUR-301 Product Picture
Figure TW-002 Product Picture
Figure AMT-090 Product Picture
Figure Others Product Picture
Figure United States Glial Cell Line Derived Neurotrophic Factor Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Glial Cell Line Derived Neurotrophic Factor by Application in 2017
Figure Amyotrophic Lateral Sclerosis Examples
Table Key Downstream Customer in Amyotrophic Lateral Sclerosis
Figure Brain Ischemia Examples
Table Key Downstream Customer in Brain Ischemia
Figure Parkinson's Disease Examples
Table Key Downstream Customer in Parkinson's Disease
Figure Retinal Degeneration Examples
Table Key Downstream Customer in Retinal Degeneration
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Glial Cell Line Derived Neurotrophic Factor Market Size (Million USD) by Region (2013-2025)
Figure The West Glial Cell Line Derived Neurotrophic Factor Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Glial Cell Line Derived Neurotrophic Factor Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Glial Cell Line Derived Neurotrophic Factor Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Glial Cell Line Derived Neurotrophic Factor Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Glial Cell Line Derived Neurotrophic Factor Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Glial Cell Line Derived Neurotrophic Factor Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Glial Cell Line Derived Neurotrophic Factor Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Glial Cell Line Derived Neurotrophic Factor Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Glial Cell Line Derived Neurotrophic Factor Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Glial Cell Line Derived Neurotrophic Factor Sales Share by Players/Suppliers
Figure 2017 United States Glial Cell Line Derived Neurotrophic Factor Sales Share by Players/Suppliers
Figure United States Glial Cell Line Derived Neurotrophic Factor Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Glial Cell Line Derived Neurotrophic Factor Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Glial Cell Line Derived Neurotrophic Factor Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Glial Cell Line Derived Neurotrophic Factor Revenue Share by Players/Suppliers
Figure 2017 United States Glial Cell Line Derived Neurotrophic Factor Revenue Share by Players/Suppliers
Table United States Market Glial Cell Line Derived Neurotrophic Factor Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Glial Cell Line Derived Neurotrophic Factor Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Glial Cell Line Derived Neurotrophic Factor Market Share of Top 3 Players/Suppliers
Figure United States Glial Cell Line Derived Neurotrophic Factor Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Glial Cell Line Derived Neurotrophic Factor Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Glial Cell Line Derived Neurotrophic Factor Product Category
Table United States Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs) by Region (2013-2018)
Table United States Glial Cell Line Derived Neurotrophic Factor Sales Share by Region (2013-2018)
Figure United States Glial Cell Line Derived Neurotrophic Factor Sales Share by Region (2013-2018)
Figure United States Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Region in 2017
Table United States Glial Cell Line Derived Neurotrophic Factor Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Glial Cell Line Derived Neurotrophic Factor Revenue Share by Region (2013-2018)
Figure United States Glial Cell Line Derived Neurotrophic Factor Revenue Market Share by Region (2013-2018)
Figure United States Glial Cell Line Derived Neurotrophic Factor Revenue Market Share by Region in 2017
Table United States Glial Cell Line Derived Neurotrophic Factor Price (USD/Pcs) by Region (2013-2018)
Table United States Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs) by Type (2013-2018)
Table United States Glial Cell Line Derived Neurotrophic Factor Sales Share by Type (2013-2018)
Figure United States Glial Cell Line Derived Neurotrophic Factor Sales Share by Type (2013-2018)
Figure United States Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Type in 2017
Table United States Glial Cell Line Derived Neurotrophic Factor Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Glial Cell Line Derived Neurotrophic Factor Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Glial Cell Line Derived Neurotrophic Factor by Type (2013-2018)
Figure Revenue Market Share of Glial Cell Line Derived Neurotrophic Factor by Type in 2017
Table United States Glial Cell Line Derived Neurotrophic Factor Price (USD/Pcs) by Types (2013-2018)
Figure United States Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate by Type (2013-2018)
Table United States Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs) by Application (2013-2018)
Table United States Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Application (2013-2018)
Figure United States Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Application (2013-2018)
Figure United States Glial Cell Line Derived Neurotrophic Factor Sales Market Share by Application in 2017
Table United States Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate by Application (2013-2018)
Figure United States Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate by Application (2013-2018)
Table GlaxoSmithKline Plc Basic Information List
Table GlaxoSmithKline Plc Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Plc Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline Plc Glial Cell Line Derived Neurotrophic Factor Sales Market Share in United States (2013-2018)
Figure GlaxoSmithKline Plc Glial Cell Line Derived Neurotrophic Factor Revenue Market Share in United States (2013-2018)
Table Treeway BV Basic Information List
Table Treeway BV Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Treeway BV Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (2013-2018)
Figure Treeway BV Glial Cell Line Derived Neurotrophic Factor Sales Market Share in United States (2013-2018)
Figure Treeway BV Glial Cell Line Derived Neurotrophic Factor Revenue Market Share in United States (2013-2018)
Table UniQure NV Basic Information List
Table UniQure NV Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure UniQure NV Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (2013-2018)
Figure UniQure NV Glial Cell Line Derived Neurotrophic Factor Sales Market Share in United States (2013-2018)
Figure UniQure NV Glial Cell Line Derived Neurotrophic Factor Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Glial Cell Line Derived Neurotrophic Factor
Figure Manufacturing Process Analysis of Glial Cell Line Derived Neurotrophic Factor
Figure Glial Cell Line Derived Neurotrophic Factor Industrial Chain Analysis
Table Raw Materials Sources of Glial Cell Line Derived Neurotrophic Factor Major Players/Suppliers in 2017
Table Major Buyers of Glial Cell Line Derived Neurotrophic Factor
Table Distributors/Traders List
Figure United States Glial Cell Line Derived Neurotrophic Factor Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Glial Cell Line Derived Neurotrophic Factor Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Glial Cell Line Derived Neurotrophic Factor Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Glial Cell Line Derived Neurotrophic Factor Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Glial Cell Line Derived Neurotrophic Factor Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Glial Cell Line Derived Neurotrophic Factor Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Glial Cell Line Derived Neurotrophic Factor Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Glial Cell Line Derived Neurotrophic Factor Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Glial Cell Line Derived Neurotrophic Factor Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Glial Cell Line Derived Neurotrophic Factor Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Glial Cell Line Derived Neurotrophic Factor Sales Volume Share Forecast by Region (2018-2025)
Figure United States Glial Cell Line Derived Neurotrophic Factor Sales Volume Share Forecast by Region (2018-2025)
Figure United States Glial Cell Line Derived Neurotrophic Factor Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources